Halftime Report cover image

Are Stocks Still Vulnerable 4/1/26

Halftime Report

00:00

Biotech Bounce After Eli Lilly Approval

Joe outlines biotech ETF strength after Eli Lilly's GLP‑1 pill approval and renewed deal activity fueling confidence.

Play episode from 38:35
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app